Table of Contents

• Michael Alvarsson,
• Göran Sundkvist,
• Ibe Lager,
• Marianne Henricsson,
• Kerstin Berntorp,
• Eva Fernqvist-Forbes,
• Lars Steen,
• Gunilla Westermark,
• Per Westermark,
• Thomas Örn,
• and Valdemar Grill

Beneficial Effects of Insulin Versus Sulphonylurea on Insulin Secretion and Metabolic Control in Recently Diagnosed Type 2 Diabetic Patients

• Sherwyn Schwartz,
• Richard Sievers,
• Poul Strange,
• William H. Lyness,
• and Priscilla Hollander

Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: Efficacy, safety, and cost analysis

• Robert S. Lindsay,
• James D. Walker,
• Peter J. Havel,
• Barbara A. Hamilton,
• Andrew A. Calder,
• and Frank D. Johnstone

Adiponectin Is Present in Cord Blood but Is Unrelated to Birth Weight

• John P. New,
• James M. Mason,
• Nick Freemantle,
• Sue Teasdale,
• Louise M. Wong,
• Nick J. Bruce,
• John A. Burns,
• and John M. Gibson

Specialist Nurse-Led Intervention to Treat and Control Hypertension and Hyperlipidemia in Diabetes (SPLINT): A randomized controlled trial

• Elizabeth A. Denver,
• Maria Barnard,
• Robin G. Woolfson,
• and Kenneth A. Earle

Management of Uncontrolled Hypertension in a Nurse-Led Clinic Compared With Conventional Care for Patients with Type 2 Diabetes

• Jennie Brand-Miller,
• Susan Hayne,
• Peter Petocz,
• and Stephen Colagiuri

Low–Glycemic Index Diets in the Management of Diabetes: A meta-analysis of randomized controlled trials

• Kasper Rossing,
• Peter Jacobsen,
• Lotte Pietraszek,
• and Hans-Henrik Parving

Renoprotective Effects of Adding Angiotensin II Receptor Blocker to Maximal Recommended Doses of ACE Inhibitor in Diabetic Nephropathy: A randomized double-blind crossover trial

• Richard W. Grant,
• Hope E. Hamrick,
• Christine M. Sullivan,
• Anil K. Dubey,
• Henry C. Chueh,
• Enrico Cagliero,
• and James B. Meigs

Impact of Population Management With Direct Physician Feedback on Care of Patients With Type 2 Diabetes

• Mayer B. Davidson

Effect of Nurse-Directed Diabetes Care in a Minority Population

• Deborah J. Toobert,
• Russell E. Glasgow,
• Lisa A. Strycker,
• Manuel Barrera, Jr.,
• Janice L. Radcliffe,
• Rosemary C. Wander,
• and John D. Bagdade

Biologic and Quality-of-Life Outcomes From the Mediterranean Lifestyle Program: A randomized clinical trial

• Andrew J. Karter,
• Mark R. Stevens,
• William H. Herman,
• Susan Ettner,
• David G. Marrero,
• Monika M. Safford,
• Michael M. Engelgau,
• J. David Curb,
• and Arleen F. Brown

Out-of-Pocket Costs and Diabetes Preventive Services: The Translating Research Into Action for Diabetes (TRIAD) study

• Michael Brandle,
• Honghong Zhou,
• Barbara R.K. Smith,
• Deanna Marriott,
• Ray Burke,
• Bahman P. Tabaei,
• Morton B. Brown,
• and William H. Herman

The Direct Medical Cost of Type 2 Diabetes

• Arran Shearer,
• Paul Scuffham,
• Adam Gordois,
• and Alan Oglesby

Predicted Costs and Outcomes From Reduced Vibration Detection in People With Diabetes in the U.S.

• Janet Thomas,
• Glenn Jones,
• Isabel Scarinci,
• and Phillip Brantley

A Descriptive and Comparative Study of the Prevalence of Depressive and Anxiety Disorders in Low-Income Adults With Type 2 Diabetes and Other Chronic Illnesses

• Luis Felipe Pallardo,
• Lucrecia Herranz,
• Pilar Martin-Vaquero,
• Teresa Garcia-Ingelmo,
• Cristina Grande,
• and Mercedes Jañez

Impaired Fasting Glucose and Impaired Glucose Tolerance in Women With Prior Gestational Diabetes Are Associated With a Different Cardiovascular Profile

• Kathryn C.B. Tan,
• Nelson M.S. Wat,
• Sidney C.F. Tam,
• Edward D. Janus,
• T.H. Lam,
• and Karen S.L. Lam

C-Reactive Protein Predicts the Deterioration of Glycemia in Chinese Subjects With Impaired Glucose Tolerance

• Daniel J. Cox,
• Jennifer Kim Penberthy,
• John Zrebiec,
• Katie Weinger,
• James E. Aikens,
• Brian Frier,
• Barbara Stetson,
• Mary DeGroot,
• Paula Trief,
• Hartmut Schaechinger,
• Norbert Hermanns,
• Linda Gonder-Frederick,
• and William Clarke

Diabetes and Driving Mishaps: Frequency and correlations from a multinational survey

• Charlotte Glümer,
• Torben Jørgensen,
• and Knut Borch-Johnsen

Prevalences of Diabetes and Impaired Glucose Regulation in a Danish Population: The Inter99 study

• Akira Katsuki,
• Yasuhiro Sumida,
• Hideki Urakawa,
• Esteban C. Gabazza,
• Shuichi Murashima,
• Noriko Maruyama,
• Kohei Morioka,
• Kaname Nakatani,
• Yutaka Yano,
• and Yukihiko Adachi

Increased Visceral Fat and Serum Levels of Triglyceride Are Associated With Insulin Resistance in Japanese Metabolically Obese, Normal Weight Subjects With Normal Glucose Tolerance

• Akihisa Imagawa,
• Toshiaki Hanafusa,
• Yasuko Uchigata,
• Azuma Kanatsuka,
• Eiji Kawasaki,
• Tetsuro Kobayashi,
• Akira Shimada,
• Ikki Shimizu,
• Tetsuya Toyoda,
• Taro Maruyama,
• and Hideichi Makino

Fulminant Type 1 Diabetes: A nationwide survey in Japan

• Graziella Bruno,
• Annibale Biggeri,
• Franco Merletti,
• Giuseppe Bargero,
• Stefania Ferrero,
• Gianfranco Pagano,
• and Paolo Cavallo Perin

Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes: A 10-year prospective study

• Thomas Danne,
• Jan Aman,
• Edith Schober,
• Dorothee Deiss,
• Judith L. Jacobsen,
• Hans Henrik Friberg,
• and Lars Hein Jensen

A Comparison of Postprandial and Preprandial Administration of Insulin Aspart in Children and Adolescents With Type 1 Diabetes

• Emily Y. Liu,
• Jean Wactawski-Wende,
• Richard P. Donahue,
• Jacek Dmochowski,
• Kathleen M. Hovey,
• and Teresa Quattrin

Does Low Bone Mineral Density Start in Post-Teenage Years in Women With Type 1 Diabetes?

• Mark S. Fineman,
• Thomas A. Bicsak,
• Larry Z. Shen,
• Kristin Taylor,
• Eling Gaines,
• Amanda Varns,
• Dennis Kim,
• and Alain D. Baron

Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

• Laurence Kessler,
• Pascal Bilbault,
• Francoise Ortéga,
• Claire Grasso,
• Raphael Passemard,
• Dominique Stephan,
• Michel Pinget,
• and Francis Schneider

Hyperbaric Oxygenation Accelerates the Healing Rate of Nonischemic Chronic Diabetic Foot Ulcers: A prospective randomized study

• Alice S. Ryan,
• Dora M. Berman,
• Barbara J. Nicklas,
• Madhur Sinha,
• Ronald L. Gingerich,
• Grady S. Meneilly,
• Josephine M. Egan,
• and Dariush Elahi

Plasma Adiponectin and Leptin Levels, Body Composition, and Glucose Utilization in Adult Women With Wide Ranges of Age and Obesity

• Kate V. Allen and
• James D. Walker

Microalbuminuria and Mortality in Long-Duration Type 1 Diabetes

• Bessie A. Young,
• Charles Maynard,
• and Edward J. Boyko

Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans

• Jakob R. Larsen,
• Hans Sjoholm,
• Kristian F. Hanssen,
• Leiv Sandvik,
• Tore J. Berg,
• and Knut Dahl-Jorgensen

Optimal Blood Glucose Control During 18 Years Preserves Peripheral Nerve Function in Patients With 30 Years’ Duration of Type 1 Diabetes

• Eray Kulcu,
• Janet A. Tamada,
• Gerard Reach,
• Russell O. Potts,
• and Matthew J. Lesho

Physiological Differences Between Interstitial Glucose and Blood Glucose Measured in Human Subjects

• Ying Wang,
• Maggie C.Y. Ng,
• Shao-Chin Lee,
• Wing-Yee So,
• Peter C.Y. Tong,
• Clive S. Cockram,
• Julian A.J.H. Critchley,
• and Juliana C.N. Chan

Phenotypic Heterogeneity and Associations of Two Aldose Reductase Gene Polymorphisms With Nephropathy and Retinopathy in Type 2 Diabetes

• Shin-ichi Araki,
• Daisuke Koya,
• Tetsuya Makiishi,
• Toshiro Sugimoto,
• Motohide Isono,
• Ryuichi Kikkawa,
• Atsunori Kashiwagi,
• and Masakazu Haneda

APOE Polymorphism and the Progression of Diabetic Nephropathy in Japanese Subjects With Type 2 Diabetes: Results of a prospective observational follow-up study

• Berthold Amann,
• Ralph Tinzmann,
• and Bernhard Angelkort

ACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1

• Hisayo Yokoyama,
• Masanori Emoto,
• Shigehiko Fujiwara,
• Koka Motoyama,
• Tomoaki Morioka,
• Miyoko Komatsu,
• Hideki Tahara,
• Tetsuo Shoji,
• Yasuhisa Okuno,
• and Yoshiki Nishizawa

Quantitative Insulin Sensitivity Check Index and the Reciprocal Index of Homeostasis Model Assessment in Normal Range Weight and Moderately Obese Type 2 Diabetic Patients

• David S.H. Bell

Heart Failure: The frequent, forgotten, and often fatal complication of diabetes

• Manju Chandran,
• Susan A. Phillips,
• Theodore Ciaraldi,
• and Robert R. Henry

Adiponectin: More Than Just Another Fat Cell Hormone?

• Russell E. Glasgow

Translating Research to Practice: Lessons learned, areas for improvement, and future directions

• Zachary T. Bloomgarden

Diabetes Issues in Women and Children: Polycystic ovary syndrome

• Kenneth M. Adams

Driving and Diabetes: One piece of the picture

• Marion J. Franz

The Glycemic Index: Not the most effective nutrition therapy intervention

• Mario R. Maldonado,
• Max E. Otiniano,
• Rebekah Lee,
• Lucille Rodriguez,
• and Ashok Balasubramanyam

Ethnic Differences in β-Cell Functional Reserve and Clinical Features in Patients With Ketosis-Prone Diabetes

• Nidhi Saxena,
• Upendra N. Dwivedi,
• Raj K. Singh,
• Arvind Kumar,
• Chhavi Saxena,
• Ram C. Saxena,
• and Mona Saxena

Modulation of Oxidative and Antioxidative Status in Diabetes by Asphaltum Panjabinum

• Nicolas Argáez-López,
• Niels H. Wacher,
• Jesus Kumate-Rodríguez,
• Miguel Cruz,
• Juan Talavera,
• Erika Rivera-Arce,
• and Xavier Lozoya

The Use of Complementary and Alternative Medicine Therapies in Type 2 Diabetic Patients in Mexico

• Dana Dawson and
• Christopher Conlon

Case Study: Metformin-Associated Lactic Acidosis: Could orlistat be relevant?

• Marian J. Vermeulen,
• Michael Klompas,
• Joel G. Ray,
• Chris Mazza,
• and Laurie J. Morrison

Subcutaneous Glucagon May Be Better Than Oral Glucose for Prehospital Treatment of Symptomatic Hypoglycemia

• Kyuzi Kamoi,
• Youichi Imamura,
• Masashi Miyakoshi,
• and Chiaki Kobayashi

Usefulness of Home Blood Pressure Measurement in the Morning in Type 1 Diabetic Patients

• Marie-Christine Beauvieux,
• Vincent Rigalleau,
• Caroline Perlemoine,
• Laurence Baillet,
• and Henri Gin

Homocysteinemia Is Not Changed by 3-Day Insulin-Induced Normoglycemia in Type 2 Diabetic Subjects

• Richard M. Davis,
• Stanley Fowler,
• Kim Bellis,
• Jeffrey Pockl,
• Vytautas al Pakalnis,
• and Andrew Woldorf

Telemedicine Improves Eye Examination Rates in Individuals With Diabetes: A model for eye-care delivery in underserved communities

• Johan G. Eriksson,
• Clive Osmond,
• Virpi Lindi,
• Matti Uusitupa,
• Tom Forsen,
• Markku Laakso,
• and David Barker

Interactions Between Peroxisome Proliferator–Activated Receptor Gene Polymorphism and Birth Length Influence Risk for Type 2 Diabetes

• Jun’ichi Yamakawa,
• Takashi Takahashi,
• Tohoru Itoh,
• Kazuya Kusaka,
• Ken Kawaura,
• Xin Qui Wang,
• and Tsugiyasu Kanda

A Novel Serotonin Blocker, Sarpogrelate, Increases Circulating Adiponectin Levels in Diabetic Patients With Arteriosclerosis Obliterans

• Gloria Kaye,
• Alison Okada Wollitzer,
• and Lois Jovanovic

Comfort and Support Improve Painful Diabetic Neuropathy, Whereas Disappointment and Frustration Deteriorate the Metabolic and Neuropathic Status Despite an Intensive Diabetes Care Program

• Ingrid I. Fruiter-Arnaudin,
• Marie M. Cohen,
• Solange S. Nervi,
• Stephanie S. Bordenave,
• Frederic F. Sannier,
• and Jean-Marie J.M. Piot

Reduced Level of Opioid Peptides, Hemorphin-7 Peptides, in Serum of Diabetic Patients

• Tomi Laitinen,
• Ilkka Vauhkonen,
• Leo Niskanen,
• Juha Hartikainen,
• Matti Uusitupa,
• and Markku Laakso

Prolonged Corrected QT Interval Is Associated With Acute and Chronic Hyperinsulinemia in Nondiabetic Subjects

• Lynne W. Scott,
• Ashok Balasubramanyam,
• Kay T. Kimball,
• Amy K. Aherns,
• C. Michael Fordis, Jr.,
• and Christie M. Ballantyne

Long-Term, Randomized Clinical Trial of Two Diets in the Metabolic Syndrome and Type 2 Diabetes

• Billie J. Barker,
• Roger R. Goodenough,
• and James M. Falko

Fenofibrate Monotherapy Induced Rhabdomyolysis

• Katherine Finucane,
• Phil Ambrey,
• Shalini Narayan,
• Clive B. Archer,
• and Colin Dayan

Insulin Injection Abscesses Caused by Mycobacterium Chelonae

• Viktor Rosival

Clarification of Statements in 2003 Clinical Practice Recommendations

• Abbas E. Kitabchi

Clarification of Statements in 2003 Clinical Practice Recommendations: Response to Rosival

• J. Hans DeVries and
• Robert J. Heine

Insulin Pump Therapy: a Meta-Analysis: Response to Weissberg-Benchell et al.

• Jill Weissberg-Benchell,
• Jeanne Antisdel-Lomaglio,
• and Roopa Seshadri

Insulin Pump Therapy: a Meta-Analysis: Response to DeVries et al.

Errata